TCF4 and Pitt-Hopkins syndrome: Mutations in TCF4 have been associated with Pitt–Hopkins syndrome (PTHS), which is characterized by severe ID, delayed motor development, seizures, wide mouth and distinctive facial features, hypotonia, microcephaly, limited walking abilities, and intermittent hyperventilation followed by apnea [31].